The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system. This finding from a new study offers a promising way to improve existing cancer therapies ...

Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

Immune Checkpoint Blockade (ICB) has reshaped cancer care and can deliver durable remission in malignancies such as melanoma and non-small cell lung cancer.

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

Could this mark a shift in how we think about cancer therapy? At least in the laboratory, evidence suggests it may be.